BBT001

Bambusa Therapeutics Reports Positive Early Phase 1 Results for BBT001 in Atopic Dermatitis

BOSTON, July 27, 2026 Bambusa Therapeutics announced encouraging preliminary proof-of-concept results from its ongoing global Phase 1 clinical trial...

By cGxPwire Editor
July 28, 2026

Bio-Pharma

Bambusa Therapeutics Completes BBT001 Trial Enrollment

BOSTON, MASSACHUSETTS, April 30, 2026 Bambusa Therapeutics has announced the successful completion of patient enrollment in its Phase 1b/2a...

By cGxPwire Editor
May 1, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

BBT001

Bambusa Therapeutics Reports Positive Early Phase 1 Results for BBT001 in Atopic Dermatitis

Bambusa Therapeutics Completes BBT001 Trial Enrollment